Companies
STOXX 600Health Care· United Kingdom
AZN
Status-Quo-PlayerAstraZeneca
$14,766.00
-1.02%
Open $15,084.00·Prev $14,918.00
Delayed
STATUS-QUO-PLAYER
Power Core
AstraZeneca's moat is a self-reinforcing oncology pipeline where each approved therapy generates clinical data, combination opportunities, and regulatory precedents that compound competitive advantage over time.
Published15 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
upward
AZN
AstraZeneca
$14,766.00
-1.02%
Open $15,084.00·Prev $14,918.00
Delayed
↑Undervalued by 88%
DCF Fair Value: $125,658.97
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.